160.45
-3.25
(-1.99%)
At close: January 21 at 2:15:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
777,228.00
790,116.00
624,804.00
900,934.00
770,402.00
Cost of Revenue
581,239.00
610,620.00
612,210.00
757,989.00
552,402.00
Gross Profit
195,989.00
179,496.00
12,594.00
142,945.00
218,000.00
Operating Expense
180,508.00
165,057.00
348,097.00
359,971.00
284,002.00
Operating Income
15,481.00
14,439.00
-335,503.00
-217,026.00
-66,002.00
Net Non Operating Interest Income Expense
-8,965.00
-7,713.00
-20,911.00
-30,092.00
-29,290.00
Pretax Income
-198,353.00
-195,660.00
-383,700.00
-238,976.00
-89,853.00
Tax Provision
259.00
259.00
-73,240.00
-45,851.00
103,822.00
Net Income Common Stockholders
-198,612.00
-195,919.00
-208,919.00
-193,125.00
-193,755.00
Diluted NI Available to Com Stockholders
-198,612.00
-195,919.00
-208,919.00
-193,125.00
-193,755.00
Basic EPS
-7.70
-7.65
-12.57
-7.67
-7.03
Diluted EPS
-7.70
-7.65
-12.57
-7.67
-7.03
Basic Average Shares
25,906.11
25,616.00
24,703.00
25,184.30
24,944.83
Diluted Average Shares
25,906.11
25,616.00
24,703.00
25,184.30
24,944.83
Rent Expense Supplemental
--
90.00
90.00
3,045.00
180.00
Total Expenses
761,747.00
775,677.00
960,307.00
1,117,960.00
836,404.00
Net Income from Continuing & Discontinued Operation
-198,612.00
-195,919.00
-208,919.00
-193,125.00
-193,755.00
Normalized Income
-198,667.30
-195,998.00
-213,066.45
-196,792.16
-193,599.60
Interest Income
--
736.00
921.00
877.00
1,694.00
Interest Expense
8,499.00
7,247.00
19,537.00
28,312.00
30,984.00
Net Interest Income
-8,965.00
-7,713.00
-20,911.00
-30,092.00
-29,290.00
EBIT
-189,854.00
-188,413.00
-364,163.00
-210,664.00
-58,869.00
EBITDA
-172,642.00
-170,680.00
-293,895.00
-137,157.00
12,564.00
Reconciled Cost of Revenue
581,239.00
610,620.00
612,210.00
757,989.00
552,402.00
Reconciled Depreciation
8,301.00
17,733.00
70,268.00
73,507.00
71,433.00
Net Income from Continuing Operation Net Minority Interest
-198,612.00
-195,919.00
-208,919.00
-193,125.00
-193,755.00
Total Unusual Items Excluding Goodwill
79.00
79.00
5,126.00
4,538.00
-222.00
Total Unusual Items
79.00
79.00
5,126.00
4,538.00
-222.00
Normalized EBITDA
-172,721.00
-170,759.00
-299,021.00
-141,695.00
12,786.00
Tax Rate for Calcs
0.00
--
0.00
0.00
0.00
Tax Effect of Unusual Items
23.70
--
978.55
870.84
-66.60
3/31/2021 - 9/5/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NATCAPSUQ.BO Natural Capsules Limited
274.85
-0.85%
INDSWFTLAB.BO Ind-Swift Laboratories Limited
114.45
+0.70%
PGHL.BO Procter & Gamble Health Limited
5,498.00
+0.11%
ASTRAZEN.NS AstraZeneca Pharma India Limited
6,752.20
-2.77%
LUPIN.BO Lupin Limited
2,103.40
-1.34%
GLS.BO Alivus Life Sciences Limited
1,080.55
-0.48%
BAJAJHCARE.BO Bajaj HealthCare Limited
606.35
-6.47%
DIVISLAB.BO Divi's Laboratories Limited
5,818.40
-2.97%
LUPIN.NS Lupin Limited
2,104.25
-1.24%
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,288.45
-1.04%